Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Shanyue Tan"'
Autor:
Rui Zheng, Ke Zhang, Shanyue Tan, Fang Gao, Yajie Zhang, Wenxia Xu, Huabin Wang, Dongying Gu, Lingjun Zhu, Shuwei Li, Haiyan Chu, Zhengdong Zhang, Lingxiang Liu, Mulong Du, Meilin Wang
Publikováno v:
Molecular Cancer, Vol 21, Iss 1, Pp 1-14 (2022)
Abstract Background Exosomes have emerged as vital biomarkers of multiple cancers and contain abundant circular RNAs (circRNAs). However, the potential for exosomal circRNAs to be used in diagnostics and their molecular mechanism of action in colorec
Externí odkaz:
https://doaj.org/article/4e86c1381a6f42fabfd9c0de4c867702
Publikováno v:
World Journal of Surgical Oncology, Vol 19, Iss 1, Pp 1-7 (2021)
Abstract Background HER2 is a member of the ERBB family of receptor tyrosine kinases, and HER2 mutations occur in 1–4% of non-small cell lung cancer (NSCLC) as an oncogenic driver mutation. We found a rare mutation of HER2 p.Asp769Tyr in NSCLC. Cas
Externí odkaz:
https://doaj.org/article/d93f651f018a4241a32241d207e7578e
Autor:
Sumeng Wang, Ke Zhang, Shanyue Tan, Junyi Xin, Qianyu Yuan, Huanhuan Xu, Xian Xu, Qi Liang, David C. Christiani, Meilin Wang, Lingxiang Liu, Mulong Du
Publikováno v:
Molecular Cancer, Vol 20, Iss 1, Pp 1-10 (2021)
Abstract Cancer is a leading cause of death worldwide, particularly because of its high mortality rate in patients who are diagnosed at late stages. Conventional biomarkers originating from blood are widely used for cancer diagnosis, but their low se
Externí odkaz:
https://doaj.org/article/2cc1469094744640a639a8342467e021
Autor:
Chongqi Sun, Yizhi Zhu, Xian Xu, Sumeng Wang, Meng Hu, Weiming Zhang, Huanhuan Xu, Qi Liang, Lingxiang Liu, Shanyue Tan, Yiqian Liu
Publikováno v:
Lung Cancer. 162:86-89
Objectives The echinoderm microtubule-associated protein-like 4 gene (EML4) and anaplastic lymphoma kinase gene (ALK) fusion is the most common ALK rearrangements in non-small cell lung cancer (NSCLC). Herein, we firstly report that coexistence of a
Publikováno v:
World Journal of Surgical Oncology, Vol 19, Iss 1, Pp 1-7 (2021)
World Journal of Surgical Oncology
World Journal of Surgical Oncology
Background HER2 is a member of the ERBB family of receptor tyrosine kinases, and HER2 mutations occur in 1–4% of non-small cell lung cancer (NSCLC) as an oncogenic driver mutation. We found a rare mutation of HER2 p.Asp769Tyr in NSCLC. Case present
Autor:
Meilin Wang, David C. Christiani, Mulong Du, Lingxiang Liu, Ke Zhang, Sumeng Wang, Qianyu Yuan, Qi Liang, Shanyue Tan, Huanhuan Xu, Xian Xu, Junyi Xin
Publikováno v:
Molecular Cancer
Molecular Cancer, Vol 20, Iss 1, Pp 1-10 (2021)
Molecular Cancer, Vol 20, Iss 1, Pp 1-10 (2021)
Cancer is a leading cause of death worldwide, particularly because of its high mortality rate in patients who are diagnosed at late stages. Conventional biomarkers originating from blood are widely used for cancer diagnosis, but their low sensitivity
Autor:
Sumeng Wang, Zhang, Ke, Shanyue Tan, Junyi Xin, Qianyu Yuan, Huanhuan Xu, Xu, Xian, Liang, Qi, Christiani, David C., Meilin Wang, Lingxiang Liu, Mulong Du
Additional file 1: Figure S1. The total number of circRNAs in the pan-cancer dataset. Supplementary Table 1. Summary of the expression pattern and sample type of circRNAs involved in pan-cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78ba3e37a2eaef672b739be2421e9feb
Publikováno v:
Journal of thoracic disease. 11(11)
Background: Published studies have presented an inconsistent association between plasma fibrinogen level and poor prognosis or clinicopathological characteristics in lung cancer. Methods: In the absence of significant quality difference, combined haz